Drug Interaction Report

Rilzabrutinib and Colchicine: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Rilzabrutinib

Wayrilz
+

Colchicine

Colcrys Colcrys® Gloperba Gloperba® Lodoco Mitigare
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Moderate
Can be significant — usually manageable with monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 123 documented Rilzabrutinib interactions, 105 are rated moderate — including this one.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Rilzabrutinib can raise colchicine levels by blocking the P-gp pump, so watch for colchicine side effects like GI upset and muscle pain; your care team can manage this by monitoring you and adjusting your colchicine dose if needed.

Here's what's going on. Rilzabrutinib (Wayrilz) can slow down a natural "pump" in your body called P-gp. Colchicine leans on that pump to get moved out of your cells. When the pump is blocked, more colchicine can build up in your body than usual.

Colchicine has a narrow safety window, so even a small increase can matter. That can mean more stomach upset, diarrhea, nausea, or muscle aches. The good news is this is a predicted (theoretical) concern, and your care team can manage it easily by keeping a closer eye on you and adjusting your colchicine dose if needed. Please don't stop either medicine on your own, just talk with your pharmacist or doctor.

Mechanism: Rilzabrutinib inhibits P-glycoprotein (P-gp)-mediated efflux. Colchicine is a P-gp substrate with a narrow therapeutic index (NTI), so reduced efflux may increase colchicine exposure (AUC/Cmax) and the risk of dose-related toxicity.

  • Direction: increased colchicine effect/exposure (neither drug is a prodrug here).
  • Severity: moderate. Onset: unspecified. Evidence: theoretical.
  • Toxicity watch: GI symptoms (nausea, vomiting, diarrhea), myopathy, myelosuppression, and in severe accumulation neuromuscular effects.

Management: Monitor more frequently for colchicine adverse reactions; the colchicine dose may need to be individualized and reduced by the care team, with heightened caution in renal or hepatic impairment.

Onset
unspecified
Evidence
theoretical
Severity
Moderate

What happens

Increased P-gp substrate with NTI exposure and an increased risk of P-gp substrate with NTI-related adverse reactions

Interaction Deep Dive

When rilzabrutinib, which inhibits P-gp, is given together with P-gp substrates that have a narrow therapeutic index (NTI), the exposure to the NTI P-gp substrate may rise, potentially heightening the likelihood of adverse reactions associated with these substrates. More frequent monitoring for adverse reactions of the P-gp substrate being used concurrently is advised1.

Why it happens (mechanism)

Inhibition of P-gp-mediated efflux transport of rilzabrutinib

How to manage this interaction

The takeaway: keep taking both medicines exactly as prescribed unless your care team tells you otherwise. This is a predicted interaction, and it is manageable.

  • Your team may monitor you more closely for colchicine side effects while you are on both drugs.
  • Your colchicine dose may need to be adjusted and individualized by your prescriber.
  • Report new or worsening diarrhea, nausea, vomiting, muscle pain or weakness, numbness, or unusual tiredness promptly.
  • Make sure your pharmacist has your full medication list and knows about any kidney or liver problems.

Check in with your pharmacist or prescriber before changing anything.

Management is individual — confirm any change with your pharmacist or prescriber.

Common questions

Can I take Rilzabrutinib and Colchicine together?

Rilzabrutinib can raise colchicine levels by blocking the P-gp pump, so watch for colchicine side effects like GI upset and muscle pain; your care team can manage this by monitoring you and adjusting your colchicine dose if needed. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Rilzabrutinib and Colchicine interaction?

It is rated moderate. Can be significant — usually manageable with monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Rilzabrutinib and Colchicine interaction managed?

The takeaway: keep taking both medicines exactly as prescribed unless your care team tells you otherwise. This is a predicted interaction, and it is manageable. Your team may monitor you more closely for colchicine side effects while you are on both drugs. Your colchicine dose may need to be adjusted and individualized by your prescriber. Report new or worsening diarrhea, nausea, vomiting, muscle… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Rilzabrutinib or Colchicine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there anything you'd monitor while I'm on both?

References (1)

  1. Product Information: WAYRILZ™ oral tablets, rilzabrutinib oral tablets. Genzyme Corporation (per FDA), Cambridge, MA, 2025. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.